Corporate Presentation
Upcoming Events & Presentations
There are no upcoming events scheduled at this time.
Past Events & Presentations
Date | Event | Webcast/Presentation |
---|---|---|
November 11, 2020 |
Third Quarter 2020 Financial Results Conference Call
|
Webcast |
September 15, 2020 |
H.C. Wainwright 22nd Annual Global Investment Conference
|
Webcast |
September 3, 2020 |
LD Micro 500 Virtual Investor Conference
|
Webcast |
August 12, 2020 |
Canaccord Genuity 40th Annual Growth Conference
|
Webcast |
August 4, 2020 |
Second Quarter 2020 Financial Results Conference Call
|
Webcast |
June 2, 2020 |
Canaccord KOL Webcast: Reviewing AWARE-1 biomarker data with Dr. Aleix Prat, MD PhD
|
Webcast |
May 20, 2020 |
RBC Global Healthcare Conference
|
Webcast |
May 7, 2020 |
Annual General Meeting
|
Webcast |
March 5, 2020 |
Fourth Quarter and Year End 2019 Financial Results Conference Call
|
|
November 12, 2019 |
Third Quarter 2019 Financial Results Conference Call
|
|
September 24, 2019 |
Ladenburg Thalmann 2019 Healthcare Conference
|
|
September 9, 2019 |
H.C. Wainwright 21st Annual Global Investment Conference
|
|
September 5, 2019 |
Oncolytics Corporate Update Call
|
|
June 5, 2019 |
Oncolytics Co-Development Agreement Call
|
|
June 4, 2019 |
LD Micro 9th Invitational Investor Conference
|
|
May 2, 2019 |
Annual General Meeting
|
|
April 30, 2019 |
2019 Bloom Burton & Co. Investor Conference
|
|
April 11, 2019 |
KOL Event: Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer
|
Presentation |
April 9 – April 10, 2019 |
Needham & Company’s 18th Annual Healthcare Conference
|
|
March 30 – April 3, 2019 |
American Association for Cancer Research
|
|
March 8, 2019 |
2018 Q4 Year End Results & Highlights Conference Call
|
|
February 11, 2019 |
BIO CEO Presentation
|
|
December 1 – December 4, 2018 |
60th Annual American Society of Hematology Annual Meeting & Exposition
|
|
November 14 – November 15, 2018 |
Jefferies 2018 London Healthcare Conference
|
|
November 12, 2018 |
Third Quarter 2018 Financial Results Conference Call
|
|
November 7 – November 11, 2018 |
Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
|
|
October 2, 2018 |
Ladenburg Thalmann Annual Healthcare Conference
|
|
September 20, 2018 |
Oncolytics Corporate & Clinical Update
|
|
August 8 – August 9, 2018 |
Canaccord Annual Growth Conference
|
|
June 4, 2018 |
American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
|
|
May 30, 2018 |
15th Annual Craig-Hallum Institutional Investor Conference
|
|
May 3, 2018 |
2018 Annual General Meeting
|
|
April 18, 2018 |
American Academy of Cancer Research (AACR) 2018 Annual Meeting
|
|
April 10, 2018 |
The MicroCap Conference
|
|
March 14, 2018 |
US Immuno-Oncology Strategy Meeting
|
|
March 6, 2018 |
2018 Precision: Breast Cancer World R&D Summit
|
|
February 23, 2018 |
Special Meeting of Shareholders
|
|
February 21, 2018 |
RBC Capital Markets Global Healthcare Conference
|
|
February 7, 2018 |
Key Opinion Leader Call: Metastatic Breast Cancer Sub-types & Today’s Treatment Paradigm
|
|
January 19, 2018 |
2018 Gastrointestinal Cancers Symposium
|
|
December 6, 2017 |
Oncolytic Virotherapy Summit
|
|
November 17, 2017 |
Oncolytics Announces Adlai Nortye Partnership
|
|
October 18, 2017 |
2017 BIO Investor Forum
|
|
August 8, 2017 |
Canaccord Annual Growth Conference
|